- HealthTech
- Friday, 20 Sep 2019
Launch of a Revolutionary diaPASEF Workflow for CCS by Bruker
Bruker has always been working towards making breakthrough technological solutions along with the scientists followed by developing applications that will enhance the living standards of the people. Alike always, the company publicizes the launch of diaPASEF Workflow for CCS (collision cross sections) at the 18th Human Proteome Organization World Congress held in Australia recently. Moreover, diaPASEF workflow is one of the new-fangled DIA (data-independent acquisition) technique over the platform of the timsTOF Pro.
Additionally, the platform leverages TIMS (trapped ion mobility spectrometry) as well as PASEF (‘parallel accumulation - serial fragmentation’) that has been built after almost seven years of alliance over several years with Professor Matthias Mann and team at Max Planck Institute in Martinsried. Along with the potent usage of ion in diaPASEF, the timsTOF pro even offers added ion mobility dimension or CCS. Also, along with retention time alignment, the platforms permits simultaneous precursors’ ion mobility alignment & fragments within diaPASEF, bettering the reliability as well as specificity of the assignments additionally.
This novel product named diaPASEF workflow as presented in ASMS (American Society for Mass Spectrometry) 2019 actually utilizes intersecting windows within the ion mobility domain in order to effectively trigger the MS/MS by the means of quadrupole for transmitting precursor ions on higher sensitivity. Also, diaPASEF ensures enhancement in protein identification almost be 30 percent. In addition to protein identification diaPASEF even ensures increases data sensitivity & completeness. Furthermore, the company has partnered with several other enterprises for the development of rapid as well as user-friendly solution for analyzing the diaPASEF data.
Beat versions for diaPASEF processing available at HUPO 2019 include Skyline (MacCoss Lab Software), Mobi-DIK (U. Toronto), Spectronaut (Biognosys AG), PEAKS (Bioinformatics Solutions Inc.), and MaxQuant (Max Planck Institute, Martinsried).
Even more appealing results in terms of the quantitative performance of diaPASEF would be presented at HUPO 2019: with the help of LFQ (label-free quantification) over the association of 3 proteomes (Yeast, HeLa & E.coli) with Spectronaut software. Hence, 8000 plus proteins would probably be accurately identified as well as quantified having at least two peptides at a success rate nearly 99 percent.
Besides, for targeted quantitative proteomics, innovative 3D-targeted PRM workflow with additional ion mobility targeting were introduced by Bruker at HUPO 2019 as work-in-progress for the targeted proteomics after sensitivity & quantitation enhancement.
Related Industry Updates
EU Opens Consultation to Modernize Energy Market Rules
Aug 21, 2025
Europe Sinus Dilation Market Report Analysis 2019-2027|Medtronic, Smith And Nephew, Johnson And Johnson Services Inc, Stryker Corporation
Apr 20, 2021
Asia Pacific Bioactive Wound Management Market Strategies, Types and Application, Forecast during 2019- 2027 | Smith & Nephew, Hartman Group, Coloplast Group
Jan 12, 2021
Patient-controlled Analgesic Infusion Pumps Market: Supply-Demand, Industry Research and End User Analysis, Outlook 2027
Feb 17, 2021
Europe Aquaculture Market Size, Share, Demand, Analysis and Forecast To 2027 | Bakkafrost,Cermaq Group AS,Cooke Aquaculture Inc.,Danish Salmon A/S,FIFAX AB,HESY AQUACULTURE B.V.,Lerøy,Mowi ASA,NIRI AS,Selonda Aquaculture SA,Stolt-Nielsen Limited,Thai Union Group PCL
Dec 04, 2020
Revolution of the Telecommunication Technology led to the Tele-Intensive Care Unit Flourish
Sep 01, 2019
MHealth is the most advanced and exciting development in ehealth
Aug 30, 2019